Cite
Xiang JF, Wang WQ, Liu L, et al. Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL. Sci Rep. 2016;6:19222doi: 10.1038/srep19222.
Xiang, J. F., Wang, W. Q., Liu, L., Xu, H. X., Wu, C. T., Yang, J. X., Qi, Z. H., Wang, Y. Q., Xu, J., Liu, C., Long, J., Ni, Q. X., Li, M., & Yu, X. J. (2016). Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL. Scientific reports, 619222. https://doi.org/10.1038/srep19222
Xiang, Jin-Feng, et al. "Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL." Scientific reports vol. 6 (2016): 19222. doi: https://doi.org/10.1038/srep19222
Xiang JF, Wang WQ, Liu L, Xu HX, Wu CT, Yang JX, Qi ZH, Wang YQ, Xu J, Liu C, Long J, Ni QX, Li M, Yu XJ. Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL. Sci Rep. 2016 Jan 12;6:19222. doi: 10.1038/srep19222. PMID: 26753987; PMCID: PMC4709775.
Copy
Download .nbib